Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021.
作者信息
Schlagenhauf Patricia, Patel Dipti, Rodriguez-Morales Alfonso J, Gautret Philippe, Grobusch Martin P, Leder Karin
机构信息
University of Zürich Centre for Travel Medicine, WHO Collaborating Centre for Travellers' Health, Epidemiology Biostatistics and Prevention Institute, Switzerland.
National Travel Health Network and Centre, UCLH NHS Foundation Trust, 250 Euston Road, London, NW1 2PG, United Kingdom.
出版信息
Travel Med Infect Dis. 2021 Mar-Apr;40:101996. doi: 10.1016/j.tmaid.2021.101996. Epub 2021 Feb 23.
Abstract
摘要
相似文献
1
Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021.
Travel Med Infect Dis. 2021 Mar-Apr;40:101996. doi: 10.1016/j.tmaid.2021.101996. Epub 2021 Feb 23.
2
Vaccination certificates, immunity passports, and test-based travel licences: Ethical, legal, and public health issues.
Travel Med Infect Dis. 2021 Jul-Aug;42:102079. doi: 10.1016/j.tmaid.2021.102079. Epub 2021 May 8.
3
Assessing US traveller vaccination access: an evaluation of US requirements for healthcare payer coverage of recommended travel vaccines.
J Travel Med. 2020 Sep 26;27(6). doi: 10.1093/jtm/taaa118.
4
Immunizations.
Med Clin North Am. 2016 Mar;100(2):247-59. doi: 10.1016/j.mcna.2015.08.018.
5
Vaccination for the expatriate and long-term traveler.
Expert Rev Vaccines. 2014 Jun;13(6):775-800. doi: 10.1586/14760584.2014.913485. Epub 2014 Apr 30.
6
Travel health: routine, recommended and required vaccines.
Br J Nurs. 2011;20(15):914-8. doi: 10.12968/bjon.2011.20.15.914.
7
How to avoid fake COVID-19 vaccine passports as a travel requirement?
J Public Health (Oxf). 2022 Dec 1;44(4):e608-e609. doi: 10.1093/pubmed/fdab308.
8
Prioritising immunisations for travel: international and Japanese perspectives.
Travel Med Infect Dis. 2014 Mar-Apr;12(2):118-28. doi: 10.1016/j.tmaid.2013.11.007. Epub 2013 Dec 12.
9
Travel medicine and vaccines for HIV-infected travelers.
Top Antivir Med. 2012 Aug-Sep;20(3):111-5.
10
[Travel vaccinations for certain groups of persons].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):85-92. doi: 10.1007/s00103-019-03067-w.
引用本文的文献
1
Epidemiological contemplation for a currently pragmatic COVID-19 health passport: a perspective.
Front Public Health. 2024 Feb 13;12:1347623. doi: 10.3389/fpubh.2024.1347623. eCollection 2024.
2
COVID-19, travel restrictions and environmental consequences.
Environ Dev Sustain. 2023 Mar 18:1-21. doi: 10.1007/s10668-023-03146-8.
3
Moving towards Digitising COVID-19 Vaccination Certificate: A Systematic Review of Literature.
Vaccines (Basel). 2022 Nov 29;10(12):2040. doi: 10.3390/vaccines10122040.
4
Airport business models and the COVID-19 pandemic: An exploration of the UK case study.
J Air Transp Manag. 2023 May;108:102337. doi: 10.1016/j.jairtraman.2022.102337. Epub 2022 Nov 23.
5
Control, Extract, Legitimate: COVID-19 and Digital Techno-opportunism across Africa.
Dev Change. 2022 Sep 27. doi: 10.1111/dech.12734.
6
Impact of perceptions and attitudes on air travel choices in the post-COVID-19 era: A cross-national analysis of stated preference data.
Travel Behav Soc. 2023 Jan;30:220-239. doi: 10.1016/j.tbs.2022.10.006. Epub 2022 Oct 11.
7
Citizens' Perception of COVID-19 Passport Usefulness: A Cross Sectional Study.
Behav Sci (Basel). 2022 May 12;12(5):140. doi: 10.3390/bs12050140.
8
Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario.
Arch Razi Inst. 2021 Nov 30;76(5):1165-1174. doi: 10.22092/ari.2021.356147.1791. eCollection 2021 Nov.
9
Assessing the effectiveness of COVID-19 vaccines in older people in Latin America.
Lancet Healthy Longev. 2022 Apr;3(4):e219-e220. doi: 10.1016/S2666-7568(22)00073-3. Epub 2022 Mar 21.
10
Urgency of COVID-19 vaccination in adolescents: Androgen and estrogen receptors view.
Travel Med Infect Dis. 2022 May-Jun;47:102306. doi: 10.1016/j.tmaid.2022.102306. Epub 2022 Mar 5.
本文引用的文献
1
SARS-CoV-2 variants and ending the COVID-19 pandemic.
Lancet. 2021 Mar 13;397(10278):952-954. doi: 10.1016/S0140-6736(21)00370-6. Epub 2021 Feb 11.
2
An action plan for pan-European defence against new SARS-CoV-2 variants.
Lancet. 2021 Feb 6;397(10273):469-470. doi: 10.1016/S0140-6736(21)00150-1. Epub 2021 Jan 21.
3
Antibody response in Dutch marines to a single intramuscular rabies booster immunization 1-2.5 years after an intradermal pre-exposure schedule: An observational study.
Travel Med Infect Dis. 2020 Nov-Dec;38:101907. doi: 10.1016/j.tmaid.2020.101907. Epub 2020 Nov 4.
4
SARS-CoV-2 vaccines in development.
Nature. 2020 Oct;586(7830):516-527. doi: 10.1038/s41586-020-2798-3. Epub 2020 Sep 23.
5
Immunity passports, fundamental rights and public health hazards: a reply to Brown .
J Med Ethics. 2020 Oct;46(10):660-661. doi: 10.1136/medethics-2020-106814. Epub 2020 Sep 9.
6
Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis.
Travel Med Infect Dis. 2020 Sep-Oct;37:101868. doi: 10.1016/j.tmaid.2020.101868. Epub 2020 Sep 6.
7
Intradermal travel vaccinations-when less means more.
Travel Med Infect Dis. 2019 Mar-Apr;28:3-5. doi: 10.1016/j.tmaid.2019.03.007. Epub 2019 Mar 13.
8
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
Mol Ther. 2019 Apr 10;27(4):757-772. doi: 10.1016/j.ymthe.2019.01.020. Epub 2019 Feb 7.
9
Ebola: Lessons on Vaccine Development.
Annu Rev Microbiol. 2018 Sep 8;72:423-446. doi: 10.1146/annurev-micro-090817-062414.
10
Experimental infection of human volunteers.
Lancet Infect Dis. 2018 Oct;18(10):e312-e322. doi: 10.1016/S1473-3099(18)30177-4. Epub 2018 Jun 18.
Zotero 插件